Your browser doesn't support javascript.
loading
Cusp overlap method for self-expanding transcatheter aortic valve replacement.
Aljabbary, Talal F; Komatsu, Ikki; Ochiai, Tomoki; Fremes, Stephen E; Ali, Noman; Burke, Lucas; Peterson, Mark D; Fam, Neil P; Wijeysundera, Harindra C; Radhakrishnan, Sam.
Afiliação
  • Aljabbary TF; Schulich Heart Program, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada.
  • Komatsu I; Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Ochiai T; Department of Cardiology, Tokyo Medical University Hospital, Tokyo, Japan.
  • Fremes SE; Schulich Heart Program, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada.
  • Ali N; Department of Cardiology, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan.
  • Burke L; Schulich Heart Program, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada.
  • Peterson MD; Division of Cardiology, Terrence Donnelly Heart Center, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Fam NP; Division of Cardiology, Terrence Donnelly Heart Center, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Wijeysundera HC; Division of Cardiology, Terrence Donnelly Heart Center, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Radhakrishnan S; Division of Cardiology, Terrence Donnelly Heart Center, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
Catheter Cardiovasc Interv ; 103(1): 202-208, 2024 01.
Article em En | MEDLINE | ID: mdl-38009641
BACKGROUND: Conduction disturbances and the need for permanent pacemaker (PPM) implantation remains a common complication for transcatheter aortic valve replacement (TAVR), particularly when self-expanding (SE) valves are used. AIMS: We compared in-hospital and 30-day rates of new PPM implantation between patients undergoing TAVR with SE valves using the conventional three-cusp coplanar implantation technique and the cusp-overlap technique. METHODS: We retrospectively compared patients without a pre-existing PPM who underwent a TAVR procedure with SE Evolut R or PRO valves using the cusp-overlap technique from July 2018 to September 2020 (n = 519) to patients who underwent TAVR using standard three-cusp technique from April 2016 to March 2017 (n = 128) in two high volume Canadian centers. RESULTS: There was no significant difference in baseline RBBB between the groups (10.4% vs. 13.2; p = 0.35). The rate of in-hospital new complete heart block (9.4% vs. 23.4%; p ≤ 0.001) and PPM implantation (8% vs. 21%; p ≤ 0.001) were significantly reduced when using the cusp-overlap technique. The incidence of new LBBB (30.4% vs. 29%; p = 0.73) was similar. At 30 days, the rates of new complete heart block (11% vs. 23%; p ≤ 0.001) and PPM implantation (10% vs. 21%, p ≤ 0.001) remained significantly lower in the cusp-overlap group, while the rate of new LBBB (35% vs. 30%; p = 0.73) was similar. CONCLUSION: Cusp-overlap approach offers several potential technical advantages compared to standard three-cusp view, and may result in lower PPM rates in TAVR with SE Evolut valve.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Marca-Passo Artificial / Próteses Valvulares Cardíacas / Bloqueio Atrioventricular / Substituição da Valva Aórtica Transcateter Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Marca-Passo Artificial / Próteses Valvulares Cardíacas / Bloqueio Atrioventricular / Substituição da Valva Aórtica Transcateter Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá